WDH · Waterdrop Inc.

$1.00 +0.00 (+0.00%) At close · Aug 17

Market Cap

$359.30M

359.30M

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue

3.98B +43.5%

FY2025

Net Income

568.94M +54.8%

FY2025

Diluted EPS

0.15 +50%

FY2025

Operating Cash Flow

243.92M -44.2%

FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics

Annual Quarterly

Line Item	3Y	5Y	10Y	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Revenue CNY	+12.4%	+5.6%	—	3.98B	2.77B	2.63B	2.8B	3.21B	3.03B	1.51B
Research & Development CNY	-7.2%	-1.0%	—	232.68M	216.5M	299.06M	291.29M	378.99M	244.23M	214.65M
Selling & Marketing CNY	+21.5%	-12.1%	—	1.12B	694.77M	740.45M	624.48M	3.1B	2.13B	1.06B
General & Administrative CNY	-7.2%	-5.3%	—	310.13M	367.65M	402.4M	388.65M	530.52M	407.17M	143M
Amortization of Intangibles CNY	-2.5%	-5.7%	—	129K	128K	138K	139K	186K	173K	0
Total Operating Expenses CNY	+15.8%	+0.5%	—	3.61B	2.59B	2.64B	2.32B	5.07B	3.52B	1.71B
Operating Income CNY	-8.1%	—	—	370.86M	178.16M	-6.74M	477.99M	-1.86B	-496.25M	-194.48M
Interest Income CNY	+18.4%	+38.6%	—	135.7M	149.12M	136.04M	81.71M	48.66M	26.52M	10.53M
Other Non-Operating Income CNY	-18.2%	+35.4%	—	36.62M	25.3M	30.6M	66.93M	9.76M	8.05M	817K
Equity in Earnings of Unconsolidated Entities CNY	—	—	—	—	—	—	—	—	-15K	-29K
Pretax Income CNY	-4.8%	—	—	543.45M	360.59M	164.24M	630.69M	-1.8B	-613.7M	-178.98M
Income Tax CNY	—	—	—	-21.61M	9.71M	555K	22.98M	-220.99M	50.16M	142.53M
Net Income CNY	-2.2%	—	—	568.94M	367.51M	167.22M	607.72M	-1.57B	-663.87M	-321.54M
Net Income Available to Common Stockholders CNY	-2.2%	—	—	568.94M	367.51M	167.22M	607.72M	-1.73B	-1.11B	-458.37M
Comprehensive Income CNY	-15.0%	—	—	453.01M	382.95M	203.08M	737.45M	-1.61B	-676.15M	-293.56M
EPS (Basic) CNY/shares	+2.2%	—	—	0.16	0.10	0.04	0.15	-0.58	-0.94	—
EPS (Diluted) CNY/shares	0.0%	—	—	0.15	0.10	0.04	0.15	-0.58	-0.94	—
Shares Outstanding (Basic Avg) shares	-2.7%	+25.2%	—	3.62B	3.65B	3.77B	3.92B	2.99B	1.17B	1.2B
Shares Outstanding (Diluted Avg) shares	-2.6%	+25.9%	—	3.71B	3.72B	3.88B	4.02B	2.99B	1.17B	1.2B

Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2024–FY2025: $289.08M in dividends.

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (CNY)

Component	FY2025	FY2024	FY2023	FY2022	FY2021
Insurance	3,576,566,000	2,363,777,000	2,340,915,000	2,559,160,000	3,071,009,000
Crowdfunding	261,636,000	267,650,000	162,683,000	155,803,000	—
All Other Segments	139,559,000	140,394,000	127,109,000	86,805,000	134,905,000

By Product & Service (CNY)

Component	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Insurance Brokerage Income	2,570,288,000	2,322,838,000	2,205,160,000	2,343,328,000	2,827,467,000	2,695,320,000	1,308,176,000
Technical Service Income	1,006,278,000	40,939,000	135,755,000	215,832,000	243,542,000	194,130,000	51,705,000
Crowdfunding Service Fees	261,636,000	267,650,000	162,683,000	155,803,000	—	—	—
Digital Clinical Trial Solution Income	118,297,000	91,066,000	100,496,000	59,456,000	566,000	—	—
Other Revenues	21,262,000	49,328,000	26,613,000	27,349,000	131,594,000	28,670,000	8,401,000
Management Fee Income	—	—	—	—	2,745,000	109,828,000	142,683,000

Segment Operating Income

Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.

By Segment (CNY)

Component	FY2025	FY2024	FY2023	FY2022	FY2021
Insurance	644,904,000	477,205,000	528,137,000	1,035,088,000	-811,319,000
All Other Segments	-91,604,000	-96,531,000	-155,235,000	-190,900,000	-150,385,000
Crowdfunding	-130,675,000	-95,084,000	-245,776,000	-254,175,000	-674,977,000

Operating Margin by Segment (%)

Component	FY2025	FY2024	FY2023	FY2022	FY2021
Insurance	18%	20.2%	22.6%	40.4%	-26.4%
Crowdfunding	-49.9%	-35.5%	-151.1%	-163.1%	—
All Other Segments	-65.6%	-68.8%	-122.1%	-219.9%	-111.5%

Key facts CIK 1823986 CUSIP 94132V105 13F (30d) 41 filings 41 filers Visit website Investor relations